Collagen Solutions PLC Attends MD&M West Conference in Anaheim

TIDMCOS

Collagen Solutions PLC

07 February 2017

Collagen Solutions Plc

(the "Company" or the "Group")

Collagen Solutions at the Medical Design and Manufacturing West Conference in Anaheim 7-9 February

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics will have representatives in attendance at the Medical Design and Manufacturing West (MD&M West) conference at the Anaheim Conference Centre in California, USA.

For 32 years, MD&M West has helped take medical devices from concept to market by uniting cutting-edge technology with the industry's foremost minds and represents the World's Largest Annual Medtech event.

It connects over 20,000 engineers and executives who are ready and willing to forge business partnerships.

Commenting on the MD&D West conference, Jamal Rushdy, CEO of Collagen Solutions said: "MD&M West is an important venue for us to demonstrate and communicate our in-house expertise in medical device development, gain first-hand understanding of what products and services are needed in numerous medical device markets, and further raise the profile of Collagen Solutions as a best-in-class manufacturer and developer of regenerative medicine devices based on our medical grade collagen and tissue technologies. Establishing this awareness is particularly important as we focus on programmes to bring finished devices to the market."

About Collagen Solutions:

Collagen Solutions Plc is a global provider of medical grade collagen formulations and components for use in regenerative medicine, medical devices and in-vitro diagnostics and research. The capabilities of the Company include the provision of native, soluble and powdered collagen formulations, processed and semi-processed tissues such as pericardium, bone, and blood vessels, and expertise in the development and contract manufacture of collagen components for use as engineered tissue scaffolds and other medical devices. These products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology. Collagen Solutions' unique offering extends beyond material supply and contract services through the highly skilled staff who support customers through the various stages of development and regulatory approval.

For additional information, please visit www.collagensolutions.com.

Enquiries:

 
  Collagen Solutions Plc                                            Contact via Walbrook 
 Jamal Rushdy, Chief Executive 
  Officer 
 Gill Black, Chief Financial 
  Officer 
 
 Cenkos Securities plc (Nominated                                     Tel: 0207 397 8900 
  Adviser and Broker) 
  Stephen Keys 
  Steve Cox 
 
 Walbrook PR                           Tel: 020 7933 8780 or collagen@walbrookpr.com 
 Mike Wort                                                            Mob: 07900 608 002 
 Anna Dunphy                                                          Mob: 07876 741 001

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAVQLFBDLFEBBV

(END) Dow Jones Newswires

February 07, 2017 02:00 ET (07:00 GMT)

Grafico Azioni Healthcare Inv (LSE:HIO)
Storico
Da Dic 2024 a Gen 2025